Page 40 - Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Material command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Material Command Today - Breaking & Trending Today

Study finds increased risk of death among breast cancer patients who drink sugar-sweetened soda


 E-Mail
IMAGE: Study first author Nadia Koyratty is an epidemiology PhD candidate in the University at Buffalo School of Public Health and Health Professions.
view more 
Credit: University at Buffalo
BUFFALO, N.Y. New research from the University at Buffalo suggests that breast cancer patients who drink sugar-sweetened beverages regularly are at increased risk for death from any cause and breast cancer in particular.
Compared to women who never or rarely drank non-diet soda, those who reported drinking non-diet soda five times or more per week had a 62% higher likelihood of dying from any causes, and were 85% more likely to die from breast cancer specifically. The findings were published online ahead of print March 2 in ....

United States , New York , Jol Freudenheim , Maurizio Trevisan , David Hill , Susan Mccann , Amy Millen , Nadia Koyratty , Nevin University , Roswell Park Comprehensive Cancer Center , National Cancer Institute , Ub School Of Public Health , Environmental Health , Health Professions , Army Medical Research , American Association For Cancer Research , National Institute On Alcohol Abuse , Department Of Epidemiology , University At Buffalo , Cancer Epidemiology , American Association , Public Health , Western New York Exposures , Breast Cancer , Material Command , National Institute ,

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®


B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
Media
Links
Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.
MELSUNGEN, GERMANY and MONMOUTH JUNCTION, N.J., March 2, 2021 – B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation, announce the launch of a global co-marketing agreement to promote the use of CytoSorb® with B. Braun’s latest OMNI® continuous blood purification platform and OMNIset® Plus bloodline set (set version 3.0 or higher). ....

United States , Holger Seeberg , Chris Cramer , Eric Kim , Amy Vogel , B Braun Avitum , Phillip Chan , Us Department Of Health , Human Services , Material Command , National Institutes Of Health , Us Air , Business Development At Cytosorbents , European Union , Us Army , Blood Institute , Cytosorbents Corporation , National Heart , Management Board , Chief Executive Officer , Vice President , Business Development , Sorbents Corporation , Use Authorization , National Institutes , Operations Command ,